< Back to Listing

AHA 2022 Presentation Slides | First-in-Human in vivo Crispr/Cas9 Editing

Download File

Image Modality: Illustration Table Figure

Description:

AHA 2022 Presentation Slides | First-in-Human in vivo Crispr/Cas9 Editing of the Ttr Gene by Ntla-2001 in Patients With Transthyretin Amyloidosis With Cardiomyopathy






Date: November 05, 2022    

Clinical Topics: Cardiovascular Care Team, Heart Failure and Cardiomyopathies

Keywords: AHA Annual Scientific Sessions, AHA22Slides, Amyloidosis, Familial, CRISPR-Cas Systems, Cardiomyopathies, Amyloid Neuropathies, Familial, Gene Editing